Changeflow GovPing Trade Procurement NIDA Funding Opportunity PAR-24-298 Expires Early
Priority review Notice Removed Final

NIDA Funding Opportunity PAR-24-298 Expires Early

Favicon for grants.nih.gov NIH Guide Funding Opportunities
Published March 11th, 2026
Detected March 11th, 2026
Email

Summary

The National Institute on Drug Abuse (NIDA) has issued a notice announcing the immediate early expiration of the funding opportunity PAR-24-298, "Mechanism for Time-Sensitive Substance Use Research (R21 Clinical Trial Optional)". No further applications will be accepted under this announcement.

What changed

The National Institute on Drug Abuse (NIDA) has issued a notice (NOT-DA-26-010) to announce the immediate early expiration of the funding opportunity announcement (FOA) PAR-24-298, titled "Mechanism for Time-Sensitive Substance Use Research (R21 Clinical Trial Optional)". This means that no new applications will be accepted for consideration under this specific FOA, effectively removing it from the available funding mechanisms.

Researchers and institutions planning to apply for this specific grant should be aware that the opportunity has closed prematurely. They must now seek alternative funding mechanisms for their time-sensitive substance use research. Inquiries regarding this early expiration can be directed to the provided email address. The original announcement for PAR-24-298 was made on September 20, 2024.

What to do next

  1. Note the early expiration of PAR-24-298
  2. Identify alternative funding opportunities for time-sensitive substance use research

Source document (simplified)

Notice to Expire PAR-24-298, "Mechanism for Time-Sensitive Substance Use Research (R21 Clinical Trial Optional)" Notice Number: NOT-DA-26-010

Key Dates

Release Date: March 11, 2026

Related Announcements

  • September 20, 2024 - Mechanism for Time-Sensitive Substance Use Research (R21 Clinical Trial Optional). See NOFO PAR-24-298.

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this Notice is to alert applicants of the early expiration of PAR-24-298 "Mechanism for Time-Sensitive Substance Use Research (R21 Clinical Trial Optional)". The Notice of Funding Opportunity (NOFO), PAR-24-298, will be expired early, effective immediately. No further applications will be accepted for consideration under this NOFO.

Inquiries

Please direct all inquiries to:

Email: [email protected]

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices Department of Health
and Human Services (HHS) NIH... Turning Discovery Into Health ®

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
Various Federal Agencies
Published
March 11th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Substantive

Who this affects

Applies to
Researchers
Geographic scope
National (US)

Taxonomy

Primary area
Education
Operational domain
Research Administration
Topics
Substance Use Research Funding Opportunities

Get Trade Procurement alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when NIH Guide Funding Opportunities publishes new changes.

Free. Unsubscribe anytime.